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Background: The annual incidence of a small indeterminate pulmonary nodule (IPN) on computed
tomography (CT) scan remains high. While traditional paradigms exist, the integration of new technologies
into these diagnostic and treatment algorithms can result in alternative, potentially more efficient methods of
managing these findings.
Methods: We report on an alternative diagnostic and therapeutic strategy for the management of an IPN.
This approach combines electromagnetic navigational bronchoscopy (ENB) with an updated approach to
placement of a pleural dye marker. This technique lends itself to a minimally invasive wedge resection via
either video-assisted thoracoscopic surgery (VATS) or a robotic approach.
Results: Subsequent to alterations in the procedure, a cohort of 22 patients with an IPN was reviewed.
Navigation was possible in 21 out of 22 patients with one patient excluded based on airway anatomy.
The remaining 21 patients underwent ENB with pleural dye marking followed by minimally invasive wedge
resection. The median size of the nodules was 13.4 mm (range: 729). There were no complications from the
ENB procedure. Indigo carmine dye was used in ten patients. Methylene blue was used in the remaining
11 patients. In 81% of cases, the visceral pleural marker was visible at the time of surgery. In one patient, there
was diffuse staining of the parietal pleura. In three additional patients, no dye was identified within the
hemithorax. In all cases where dye marker was present on the visceral pleural surface, it was in proximity to
the IPN and part of the excised specimen.
Conclusions: ENB with pleural dye marking can provide a safe and effective method to localize an IPN and
can allow for subsequent minimally invasive resection. Depending on the characteristics and location of the
nodule, this method may allow more rapid identification intraoperatively.
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A
s a consequence of increased utilization of com-
puted tomography (CT) scans of the chest, every
year thousands of patients are discovered to have
an indeterminate pulmonary nodule (IPN) (1). Recently,
the National Lung Cancer Screening trial demonstrated
a relative risk reduction in lung cancer death of 20% in
patients at high risk of lung cancer who were randomized
to three serial low-dose CT scans compared to single
posterioranterior chest radiography. It is important to
note that of those patients with positive screening re-
sults, 96.4% were ultimately found to be false positives (2).
CT scanning of the chest is used to interrogate a vari-
ety of pulmonary related complaints including short-
ness of breath and chest pain. As a result, numerous
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CT scanning is often used as a tool for surveillance
imaging in patients with a history of prior malignancies.
While there are effective paradigms for the manage-
ment of these nodules, the advent of new technologies
may alter these approaches and result in new treatment
algorithms to obtain an accurate diagnosis in a minimally
invasive fashion.
The current approaches in the evaluation of an IPN
include a variety of different methods from continued
surveillance imaging, as well as procedural approaches
to obtain tissue for a diagnosis. The options for bio-
psy include CT-guided transthoracic needle aspiration
(TTNA), standard flexible bronchoscopy (FOB) with
transbronchial biopsies (TBBx), and surgical resection
(3). Avariety of factors are accounted for when determin-
ing the optimal investigational approach for each patient.
The modality selected to diagnose a suspected lung can-
cer is often based on the size and location of the primary
lesion in the lung, the presence of potential metastatic
spread, and the anticipated treatment plan (4). While each
approach has its benefits as well as its limitations, a
combined approach that utilizes the advantages of differ-
ent modalities might result in a more efficient method in
the management of IPNs. Such an approach might ensure
a higher likelihood of accurately diagnosing both benign
and malignant disease processes and improve the selection
of appropriate patients for resection. To date, several
techniques have been described to localize IPNs for
operative excision (58). The vast majority of these
approaches use a percutaneous technique, wherein pleural
markers,wires,coilsorradioactivetracersareplacedusing
CTguidance.Theseapproachesaretypicallyfollowedbya
video-assisted thoracoscopic surgery (VATS) exploration
to identify the IPN that is then followed by resection.
An additional option utilizes CT-fluoroscopy-guided
bronchoscopy in conjunction with Teflon coated catheter
followed by dye marking of the pleural surface. The IPNs
were not biopsied during these approaches for several
reasons and VATS was still performed (8).
Herein, we describe a novel modality using an
endobronchial approach that combines electromagnetic
navigational bronchoscopy (ENB) with dye marker place-
ment, and in this application done in conjunction with
minimally invasive wedge resection as an alternative
approach to managing IPNs. This provides a means
to accurately diagnose and potentially treat IPNs while
minimizing risk and invasiveness. Being able to visualize
the dye marker during operation may allow the surgeon to
localize the nodule with greater ease and thus potentially
allow procedures to be completed in a minimally invasive
fashion. We initially reported on this technique in abstract
form several years ago (9). While this approach demon-
strated potential, there were several difficulties. These
included soiling of the pleural spacewith the dye aswell as
communication issues with respect to the physician pla-
cing the marker and the physician performing the resec-
tion in the setting where these were not the same people.
These technical issues have been addressed with the new
technique and subsequent results described. The goal was
to facilitate the diagnosis of the IPN as well as to improve
the efficiency of the procedure by decreasing the time
associated with the resection and minimize the morbidity
by decreasing the conversion rate to open thoracotomy.
Patients and methods
This is a retrospective, multi-institutional study to review
the safety and results of ENB dye marker placement
followed by minimally invasive wedge resection given the
alterations in the technique. Specifically, these altera-
tions included a tenting technique whereby the subpleural
space was ‘tented’ with the locatable guide (LG) and
extended working channel (EWC) under fluoroscopy to
enhance localization, described below, and, in the in-
stances where the physicians placing the marker and
doing the resection were not the same, communication
issues and directed review of the site of placement
utilizing the navigational software was conducted. The
procedures were completed at four different institutions.
Each institution’s IRB approved this study. Individual
patient informed consent was obtained where appropriate.
The technique of dye marker placement is described in
the following paragraph.
ENB (SuperDimension, Plymouth, MN) was perfor-
med under general anesthesia or monitored anesthesia
care with sedation. A therapeutic bronchoscope (Olympus
BF 1T180) in conjunction with the navigational system
was used in accordance with the manufacturer’s instruc-
tions and as described in the literature (10). Occasionally,
proximity to the target IPN was confirmed by passing
an ultrasound miniprobe (Olympus UM-20-S20) through
the EWC. If biopsies were performed, these were done
prior to dye marking and submitted for pathologic exam-
ination. Once the target lesion was reached, the LG and
EWC were advanced using fluoroscopy to approximate
the visceral pleural surface. This allowed for the most
direct route from the lesion to the visceral pleural surface
The LG has a blunt tip and is able to ‘tent’ the pleural
surface when advanced under fluoroscopic visualization.
The EWC was then locked at this position and a 25-gauge
sclerotherapy needle replaced the LG. Approximately
0.25 ml of dye was then injected at this site. Again, either
indigo carmine dye or methylene blue was utilized for
dye marker placement. Both have been found to be safe
and effective in humans and have utility in many organ
systems including the lung (11, 12). Once the dye was
injected, if there was no soiling of the airways, then an
additional 0.25 ml was injected for a total of 0.5 ml.
Again, in those instances where the physicians injecting
the dye and performing the resections where not one
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software was then conducted to access the position of the
mark.
Following dye marker placement, patients were taken
to the operating room for minimally invasive wedge re-
section either by a VATS or robotic approach. Depending
on the patient characteristics and frozen section analysis,
a formal anatomic resection with lymph node dissection
was completed at the same time.
Results
Patient demographics are listed in Table 1. Twenty-
two patients with a pulmonary lesion suspicious for
malignancy were recruited, with one exclusion secondary
to airway anatomy resulting in the inability to advance
the catheter. This was subsequently located thoracosco-
pically. Twenty-one patients underwent ENB with dye
marker placement followed by minimally invasive wedge
resection. Indigo carmine dye was used in ten patients
and methylene was used in the remaining 11 patients.
VATS performed 17 operations and four were completed
by a completely portal robotic technique. At the time of
operation, the dye marker was visible in 81% patients
and outlined the area for excisional biopsy (Fig. 1). One
patient had diffuse dye marker staining of the parietal
pleura and in three patients no dye marker was visualized
within the hemithorax. No cases required conversion to
an open procedure to identify the nodule. Characteristics
of the nodules are listed in Table 2. The mean nodule size
was 13.4 mm with size range from 7 to 30 mm. Pathologic
examination showed that eight patients (38%) had benign
disease. Eight patients (38%) had metastatic lesions. The
remaining five patients (24%) had primary non-small cell
lung cancer and underwent subsequent lobectomy and
thoracic lymphadenectomy.
Comment
The renewed interest in screening CTs for the detection
of lung cancer in at-risk patients, the increased utilization
of CT scanning to evaluate respiratory symptoms as
well as to survey those patients with prior malignancies
will result in the detection of many pulmonary nodules,
the majority of which will be benign (2). Historically,
thoracoscopies done in these settings, i.e., an indeter-
minate chest lesion or nodule, typically results in an
approximately 50% conversion rate to an open, and con-
sequently more invasive procedure (13). Thus, it would
appear that the combination of navigational broncho-
scopy with pleural dye marking represents a distinct,
stepwise approach in the management of the IPN with
the potential to decrease the rate to an open thoracotomy.
In this cohort of patients, with the exception of the
pleural dye mark, the visceral pleura was otherwise un-
remarkable and there were no other visual cues to suggest
the location of the IPNs. Further, the presence of the dye
marker allowed efficient localization of the nodule/area
of interest and completion of the operation. In addition
to the potential to decrease the conversion rate to an
open thoracotomy, and thus a more invasive procedure,
the advantages of this technique include the potential
for shorter operative time due to more rapid localization
of the nodule, as well as providing avisual cue in difficult
to palpate or non-palpable aberrancies such as ground
glass opacities, etc. This approach, as a consequence
of the enhanced localization, also has the potential to
decrease the amount of resected tissue necessary during
the excisional phase of the procedure.
The options for blue dye marker include indigo car-
mine dye or methylene blue. The technique for injection
through a 25-gauge sclerotherapy needle as described
above is the same for both dye markers. The duration of
time between dye marker placement and operation does
influence the choice of marker. Both dyes have been used
to help localize pulmonary nodules for resection. Indigo
carmine dye has an advantage in that the dye can be
visible to the surgeon at least 3 days after marking (11).
In contrast, methylene blue will diffuse more rapidly
through the tissues in several hours, which may inhibit
precise localization of the nodule to allow for a more
limited resection (14). If the resection is to occur im-
mediately following dye marker placement, either indigo
carmine or methylene blue can be used. However, if the
operation is going to occur on a different day, indigo
carmine dye should be used. Either dye can be used
Table 1. Baseline characteristics of patients undergoing
ENB prior to VATS
Total patients; n 21
Sex
Male; n (%) 11 (52)
Female; n (%) 10 (48)
Age; mean (range) 66 (4787)
ENB able to reach target; n (%) 21 (95)
Dye used
Indigo carmine; n (%) 10 (48)
Methylene blue; n (%) 11 (52)
Operation performed
VATS 17 (81)
Robotic resection 4 (19)
Dye visible; n (%) 18 (86)
Final diagnosis
Benign; n (%) 8 (38)
Sarcoidosis; n (%) 1 (5)
Harmatoma; n (%) 1 (5)
Histoplasmosis; n (%) 1 (5)
Other benign tissue; n (%) 5 (24)
Metastatic disease; n (%) 8 (38)
Non-small cell lung cancer; n (%) 5 (24)
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occurs immediately following dye marking.
Other techniques have been described to assist in
intraoperative localization of a pulmonary nodule. These
include needle localization by interventional radiology,
percutaneous or CT guided bronchoscopic injection of
dye marker, and placement of a fiducial marker for digital
palpation (1517). An additional option includes injec-
tion of a radionuclide followed by intraoperative gamma
probe localization of the nodule (18). When properly
performed, all of these techniques can be useful. Dis-
advantages of needle localization include concerns of
needle movement, creation of a parenchyma hematoma,
or symptomatic pneumothorax prior to resection. Per-
cutaneous placement of dye or a fiducial can also be
complicated by pneumothorax. Additionally, the relative
inability to provide any diagnostic tissue no matter the
situation would seem to further limit these approaches.
Based upon our personal experience, the CT-guided ap-
proach to dye placement is cumbersome. Although the
actual procedure time has been reported as approximately
30 minutes, there is additional time to obtain CT scanner
availability as well as patient positioning in the CT scan-
ner and equipment positioning around the CT scanner
(11). Additionally, the CT-guided bronchoscopic method
is without the steering capability associated with the
navigational approach.
In comparison, the advantages of this approach in-
clude: the lower pneumothorax rate associatedwith bron-
choscopy, the ability to perform marker placement and
resection in one procedure, the steerability and enhanced
endoscopic localization of navigation as well as the ability
to obtain tissue biopsies at the same time if needed.
Additionally, if at the time of the bronchoscopic biopsy, a
lesional, confirmatory non-malignant diagnosis is found,
this might obviate the need for additional procedures
unlike the other methods described above. This technique
can also be performed in the same operating theater
just prior to the VATS procedure while the patient
is anesthetized, thus potentially allowing for a more
efficient and cost-effective approach.
There are many techniques and treatment algorithms
availabletoevaluatetheIPN.Themethodsandtechniques
described herein are not meant to replace other options.
Rather, ENB with dye marker placement followed by
operative resection provides another approach in the
evaluation and management of the IPN with an efficient
and stepwise approach. In addition, it appears to be safe
and reproducible in avariety of different practice settings.
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Fig. 1. (A, B) Initial thoracoscopic view; (C, D) stained portion being resected during VATS.
Table 2. Characteristics of nodules
Total number of nodules; n 21
Nodule size (greatest diameter, mm); mean (range) 13.4 (730)
Location
RUL; n (%) 5 (24)
RML; n (%) 3 (14)
RLL; n (%) 5 (24)
LUL (excluding lingua); n (%) 3 (14)
Lingula; n (%) 1 (5)
LLL; n (%) 4 (19)
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